NuVasive, Inc., has extended its foray into limb lengthening technology with the launch of the Precice® Plate. The San Diego, California-based orthopedics device company had been a pure-player in the spine device arena until just a couple of years ago with the launch of the Precice limb lengthening intermedullary nail.
Just like the internally implanted nail, the Precice plate is expanded via an external magnetic controller. The device was developed by NuVasive Specialized Orthopedics™ (NSO) a division of NuVasive that applies the magnetic expansion technology to a series of devices. The benefits of the plate are targeted toward pediatric patients with anatomy that is too small to accommodate the intermedullary nail options, such as the Precice Stryde.
Dror Paley, M.D., director of the Paley Orthopedic and Spine Institute at St. Mary’s Medical Center in West Palm Beach, Florida, described his experience with the plate in a press release from NuVasive. “The Precice Plate represents a first-of-its-kind limb lengthening solution for pediatric patients that allows for internal lengthening while avoiding potential damage to their growth plates… Now, with the Precice Plate, I can finally offer these patients a minimally invasive technique to lengthen their bones for the correction of limb length discrepancy.”
The plate is also more easily removed after the desired limb length is achieved than internally implanted options. The device was developed in collaboration with limb lengthening reconstruction experts, such as Shawn Standard, M.D., orthopedic surgeon and head of pediatric orthopedics at the International Center for Limb Lengthening at the Rubin Institute of Advanced Orthopedics at Sinai Hospital in Baltimore, Maryland. Standard described the impact the Precice Plate has had on his practice, saying it “…will completely change reconstruction methods and modernize the way we approach and treat pediatric limb reconstruction, and I am honored to have played a key role in bringing this highly anticipated product to market.”
Rob Martin, General Manager of NSO, is pleased to have contributed to “NuVasive's commitment to grow its proprietary technology in previously underserved markets and deliver better patient outcomes. Together with our team of design surgeons, we celebrate a significant milestone of advancing pediatric care.”
The Precice Plate received FDA 510(k) clearance in November 2019, and is indicated for use in children or small stature adults. In addition to limb lengthening, it is also indicated for fracture fixation, pseudarthrosis, mal-union, and non-union of long bones.
Post time: Dec-20-2020